4D Molecular Therapeutics (4DMT) has said a trial of its gene therapy for Fabry disease has been placed on a clinical hold by the FDA, a few weeks after it reported three cases of atypical haemolytic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results